Who owns Kojin Therapeutics?

Kojin Therapeutics is formerly owned by Cathay Capital, through Cathay Health, since 2021.

When did Cathay Capital acquire Kojin Therapeutics?

Cathay Capital acquired Kojin Therapeutics in 2021 and exited after 4 years.

Has Kojin Therapeutics been sold?

Yes. Kojin Therapeutics was exited in 2025 via Write-off.

Home/Companies/Healthcare/Kojin Therapeutics

Kojin Therapeutics

Healthcare·

US·Exited 2025·Held 4yr

Kojin Therapeutics is a healthcare company, headquartered in United States.

Entry

2021

Hold

4yr

Exit

2025

Est. EV

–

Investor

Cathay Capital

Key facts

HQUnited States

SectorHealthcare

Kojin Therapeutics is the first biopharmaceutical company using a proprietary approach to cell state and ferroptosis biology to develop…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Exit details: type, year, MOIC (buyer on Pro)

Start free

Already a member? Sign in

More from Cathay Health

Other portfolio companies in the same fund.

Ascend Gene & Cell Therapies

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.

Last updated April 2026 · Sourced from public filings